Skip to main content
españolES
European Commission logo print header

Tomographic 3D Ultrasound for Safe and More Cost Effective Vascular Diagnostics and Treatment Planning

Objetivo

Annually, cardiovascular disease (CVD) causes over 4m deaths in Europe and 17.3m deaths globally, and is expected to
grow to over 23.6m by 2030. It accounts for 40% of deaths in the EU and costs the EU economy almost €196bn each year.
2D ultrasound scans are currently the primary choice for vascular diagnostics. Due to low sensitivity, a limited field of action
and the lack of volume information, patients are often referred for CTa, MRa and catheter angiography for the detailed
imaging required for diagnosis and treatment planning. Referrals delay treatment, exposes the patient to risks associated
with radiation and contrast mediums and increases costs. This presents a need to improve the speed and safety of the
diagnosis of vascular conditions for rapid treatment, as well as to improve workflow efficiency and reduce costs. The project
consortium will further develop the piur tUS system, a 3D freehand tomographic US system capable of rapid, safe and
accurate reconstructive 3D quantifiable vascular imaging. It will provide a low cost and reproducible imaging solution that will
reduce the need for referrals and be an effective preventative screening tool for CVD. We aim to complete and publish the
results from 4 CVD clinical studies to generate the clinical evidence required for CE marking and clinical validation for market
uptake. The 4 clinical applications studied will provide a solution for conditions most frequently referred for detailed 3D
imaging to maximise the cost-benefit to clinics of purchasing the piur tUS system. The project consortium combines piur
imaging’s expertise in medical device development and commercialisation with 3D imaging specialist ImFusion GmbH and
medical device product development and manufacturing experts ACMIT. The clinical input for the product development and
the clinical studies will be provided by our consortium partners, Independent Vascular Services Ltd and the Institute for
Cardiovascular Science: University of Manchester

Ámbito científico

Programa(s)

Tema(s)

Convocatoria de propuestas

H2020-FTIPilot-2016

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-FTIPilot-2016-1

Régimen de financiación

IA - Innovation action

Coordinador

INDEPENDENT VASCULAR SERVICES LIMITED
Aportación neta de la UEn
€ 551 583,38
Dirección
19 LEE BANK WESTHOUGHTON
BL5 3HQ BOLTON
Reino Unido

Ver en el mapa
Pyme

Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.
Sí
Región
North West (England) Greater Manchester Greater Manchester North West
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 787 976,25

Participantes (4)

Compartir esta página

Descargar

Última actualización: 16 Agosto 2022

Mi folleto

Permalink: https://cordis.europa.eu/project/id/760380/es

European Union, 2024